Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 22.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation, EISAI, Genentech, and Novartis Oncology.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

12th Annual School of Breast Oncology®

12th Annual School of Breast Oncology®


Overview

An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators. The School of Breast Oncology® not only provides a comprehensive overview for fellows or oncologists who are new to practice, but also serves as a valuable refresher course with updates on the latest data and changes to standards of care for the oncologist who has been in practice for several years or more.


Target Audience

This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.


Program Director

Joyce O'Shaughnessy, MD
Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
The US Oncology Network
Dallas, TX







Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with the ACCME Standards for Commercial SupportSM, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to start of each activity. Participants are notified prior to the activity of the presence or absence of relevant financial relationships between faculty and commercial interests. Information disclosed includes the name of the faculty, nature of the relevant financial relationship (e.g., member of speaker's bureau, grant/research support, or consulting arrangement), and the name of the company/organization with which the relationship exists. Additionally, prior to the start of each activity PER® discloses the source of commercial support to the participants.


Faculty, Staff, and Planners' Disclosures

The following individuals have no relevant financial relationships with commercial interests to disclose:

Douglas Arthur, MD; David Euhus, MD, FACS; Carol Fabian, MD; William J. Gradishar, MD, FASCO, FACP; Karin Hahn, MD, MSc, MPH; M. Elizabeth H. Hammond, MD; Syed Hoda, MD; Frankie Ann Holmes, MD, FACP; Anne McTiernan, MD, PhD; Anne Moore, MD; David M. Schuster, MD; Lawrence Solin, MD, FACR, FASTRO; Jeffrey N. Weitzel, MD

The staff of Physicians' Education Resource®, LLC: Ann C. Lichti, CCMEP; Susan Peck, PhD; and Emily Valko Lohrmann

The following individuals have relevant financial relationships with commercial interests to disclose:

Carey Anders, MD -- Grant/ Research Support: Novartis, sanofi-aventis, to-BBB Therapeutics, Geron Corporation, AngioChem, Merrimack Pharmaceuticals, Bristol-Myers Squibb, Puma Biotechnology; Consultant: Novartis, sanofi-aventis, to-BBB Therapeutics, Geron, AngioChem, Merrimack Pharmaceuticals -- all uncompensated; Claudine Isaacs, MD -- Grant/ Research Support: Novartis; Speaker's Bureau: Genentech, Celgene Corporation; Jennifer R. Klemp, PhD, MPH, MA -- Stock/ Shareholder: Founder and CEO of Cancer Survivorship Training, Inc (no salary is received); Henry M. Kuerer, MD, PhD, FACS -- Advisory Board: Lightpoint Medical, Inc; Charles Loprinzi, MD -- Grant/Research Support: Pfizer, Competitive Technologies; Terry Mamounas, MD -- Consultant: Genomic Health Inc., Celgene Corporation, Pfizer, GlaxoSmithKline, Eisai, GE Healthcare; Speaker's Bureau: Genomic Health Inc., Roche/ Genentech; Ruth O'Regan, MD -- Grant/Research Support: Novartis; Consultant: Novartis, Roche; Joyce O'Shaughnessy, MD -- Advisory Board/ Consultant: Arno Therapeutics, Celgene Corporation, Corcept Therapeutics, Eisai, Genentech, GlaxoSmithKline, Johnson & Johnson, Lilly, med fusion, LLC, Merrimack Pharmaceuticals, Millennium: The Takeda Oncology Company, Novartis, Pfizer, sanofi-aventis; Lori J. Pierce, MD, FASTRO -- Grant/ Research Support: Blue Cross Blue Shield, Komen, BCRV; Elizabeth Rafferty, MD -- Grant/Research Support: Principal Investigator, Research Grant from Hologic, Inc. for investigation of breast tomosynthesis; Edward Romond, MD -- Grant/ Research Support: Genentech/ Roche; Hope Rugo, MD -- Grant/Research Support: GlaxoSmithKline, Genentech/Roche, Novartis, Merck, Amgen, Eisai, Plexxikon, Pfizer, Macrogenics, Celsion; Speaker's Bureau: Genomic Health; Hani Sbitany, MD -- Speaker's Bureau: LifeCell, Inc.; Joseph Sparano, MD -- Grant/Research Support: Merck; Consultant: Genentech, Celldex Therapeutics, MetaStat; Catherine Van Poznak, MD -- Grant/ Research Support: Amgen, Novartis; Consultant: Novartis.


Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC.

*Information accurate at time of posting


Physician Payments Sunshine Act

Physicians' Education Resource®, LLC, complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.








Become a Member

Forgot Password?
Filter By